ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 55 filers reported holding ONCOMED PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $1,704,000 | +581.6% | 138,394 | +459.7% | 0.31% | +769.4% |
Q1 2016 | $250,000 | -81.8% | 24,726 | -70.2% | 0.04% | -72.7% |
Q3 2015 | $1,374,000 | +76.8% | 82,843 | +139.8% | 0.13% | +73.7% |
Q2 2015 | $777,000 | +53.0% | 34,548 | +4.2% | 0.08% | +230.4% |
Q3 2013 | $508,000 | – | 33,160 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 4,400,289 | $19,889,000 | 2.53% |
ADAMS STREET PARTNERS LLC | 1,473,061 | $6,658,000 | 1.70% |
Iguana Healthcare Management, LLC | 700,000 | $3,164,000 | 0.87% |
Perceptive Advisors | 2,076,578 | $9,386,000 | 0.18% |
Birchview Capital, LP | 28,689 | $130,000 | 0.07% |
Cannell & Co. | 303,971 | $1,374,000 | 0.05% |
ELEMENT CAPITAL MANAGEMENT LLC | 25,249 | $114,000 | 0.05% |
NJ State Employees Deferred Compensation Plan | 38,000 | $172,000 | 0.03% |
DISCIPLINED GROWTH INVESTORS INC /MN | 313,775 | $1,418,000 | 0.03% |
Candriam S.C.A. | 370,000 | $1,672,000 | 0.03% |